Illumina (NASDAQ:ILMN) Price Target Cut to $164.00

Illumina (NASDAQ:ILMN – Free Report) had its target price cut by Scotiabank from $176.00 to $164.00 in a research report report published on Thursday morning, Benzinga reports. They currently have a sector outperform rating on the life sciences company’s stock. Several other equities research analysts have also recently weighed in on ILMN. UBS Group increased […]

Leave a Reply

Your email address will not be published.

Previous post Beat workweek worries with preparation, mindset
Next post Delcath Systems (NASDAQ:DCTH) Upgraded at StockNews.com